These findings indicate that, PPAR δ may inhibit tumor growth by inducing differentiation, attenuating cell proliferation and VEGF-mediated angiogenesis in the pathogenesis of colon cancer, and facilitate the tumor sensitivity to bevacizumab. The gene discussed is VEGFA; the disease is malignant colon neoplasm.